APA (7th ed.) Citation

EM, T., DM, A., K, A., P, N., G, A., ED, B., . . . D, L. (2025). A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: A phase 1 trial. Nature cancer, 6(9), 1559. https://doi.org/10.1038/s43018-025-00998-z

Chicago Style (17th ed.) Citation

EM, Thompson, et al. "A Peptide Vaccine Targeting the CMV Antigen Pp65 in Children and Young Adults with Recurrent High-grade Glioma and Medulloblastoma: A Phase 1 Trial." Nature Cancer 6, no. 9 (2025): 1559. https://doi.org/10.1038/s43018-025-00998-z.

MLA (9th ed.) Citation

EM, Thompson, et al. "A Peptide Vaccine Targeting the CMV Antigen Pp65 in Children and Young Adults with Recurrent High-grade Glioma and Medulloblastoma: A Phase 1 Trial." Nature Cancer, vol. 6, no. 9, 2025, p. 1559, https://doi.org/10.1038/s43018-025-00998-z.